Vioguard LLC announces that it has finalized a patent sale agreement with Microsoft Corporation (MSFT). The agreement included the sale of two U.S. patents for sterilizing surfaces on input devices by Microsoft to Vioguard. The patents are for disinfecting surfaces such as computer keyboards, touchscreens and miscellaneous input devices. The specific terms of the agreement were not disclosed.
"The acquisition of these patents allows Vioguard to broaden our lead in the ultraviolet disinfection arena," says Laurance Ranta, president and CEO of Vioguard. “We are pleased to enter into this agreement with Microsoft.”
Vioguard's keyboard uses high-powered germicidal ultraviolet light, otherwise known as UV-C, at 254 nm wavelength. The keyboard uses UV-C lamps with a reflector and diffuser to distribute the light evenly. Based on published data, this level of UV-C will kill more than 99.99 percent of harmful microorganisms such as MRSA, mold, and other contaminants within seconds.
"Transformative technologies, such as those involved here, are made possible by a patent system that incentivizes innovation and research,” says Nick Psyhogeos, general manager and associate general counsel of IP licensing in the Innovation and Intellectual Property Group at Microsoft. “We’re pleased to sell these patents to Vioguard as they bring their UVC solution to the market."
Source: Vioguard
The Role of Environmental Hygiene in Preventing Antimicrobial Resistance
March 19th 2024Uncover the pivotal role of environmental hygiene in thwarting antimicrobial resistance (AMR) for infection prevention teams. Learn how rigorous cleaning protocols and advanced technologies enhance patient safety and combat AMR.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.